Clinical High Risk clinical trials

Explore recruiting clinical high risk clinical trials.

Recruiting clinical high risk studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clinical High Risk trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE 2, MULTI-COHORT, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BB2121 IN SUBJECTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA AND IN SUBJECTS WITH CLINICAL HIGH-RISK MULTIPLE MYELOMA

Spain, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Clinical High Risk trials by city

Clinical High Risk in Toronto Clinical High Risk in Vancouver Clinical High Risk in Montreal Clinical High Risk in Calgary Clinical High Risk in Edmonton Clinical High Risk in Ottawa Clinical High Risk in Winnipeg Clinical High Risk in Quebec City Clinical High Risk in Hamilton Clinical High Risk in Kitchener Clinical High Risk in London Clinical High Risk in Halifax Clinical High Risk in New York Clinical High Risk in Los Angeles Clinical High Risk in Chicago Clinical High Risk in Houston

Clinical High Risk clinical trials

Recruiting clinical high risk studies right now

Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

Technology-enabled Management Versus Usual Care for Blood Pressure

Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma

Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer

Evaluation of a High Protein Plant Dominant Diet (HiProPlaDo) in Liver Cirrhosis

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence

Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)

Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

Also recruiting in Europe

A PHASE 2, MULTI-COHORT, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BB2121 IN SUBJECTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA AND IN SUBJECTS WITH CLINICAL HIGH-RISK MULTIPLE MYELOMA

Clinical High Risk trials by city

Other conditions